GLP-3 is not a standard pharmacology name; on research-vendor sites it is used as shorthand for a multi-incretin research compound that acts on more than one metabolic receptor pathway. Because that naming is vendor-dependent, the exact identity should be checked on the product page or certificate of analysis. It is therefore best understood as a multi-pathway metabolic research compound.
Frequently Asked Questions
Explore answers to our most commonly asked questions about CBD, our products, and more.
In published laboratory work, multi-incretin research compounds of this class are studied for receptor-signaling behaviour across more than one metabolic pathway, for comparative potency against single-pathway incretin peptides, and for analytical characterization such as purity, identity and stability testing. All material sold here is supplied for research use only and is not intended for human or animal use, diagnosis, or treatment.